Showing results (71-80 of 344) with videos related to
Sort By:
Pageof 35
Journal of Market Access & Health Policy|October 31, 2017
The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy changeK E Young, I Soussi, M ToumiJournal of Market Access & Health Policy|May 27, 2026
Impact of Market Access Delays on Time to Patient Access: Multi-Country Comparative Analysis Assessing the First Commercial Launch Indications for Five Oncology Medicines Across Europe and CanadaBarry Crean, David Parry, Alison Horsfield, et al.Journal of Market Access & Health Policy|August 26, 2026
Multi-Criteria Decision-Making Framework for Sustainable Innovation Management in the Mexican Medical Device Manufacturing Industry: An Exploratory and Interdisciplinary AnalysisJosé Cozain-Hernández, Josué Aarón López-Leyva, Miguel Angel Ponce-Camacho, et al.Journal of Market Access & Health Policy|August 26, 2026
The European Union's Health Technology Assessment Regulation (EU-HTA R) Will Prosper Despite Major SetbacksMondher Toumi, Imen Soussi, Bruno Falissard, et al.Journal of Market Access & Health Policy|August 26, 2026
Health-Related Quality of Life of Patients with Epidermolysis bullosa and Carers Using a Time Trade-Off Approach in the UK General Population to Elicit Utilities for Health Technology AssessmentLuke Stainer, George Morgan, Thomas Snell, et al.Journal of Market Access & Health Policy|August 26, 2026
A Real-World Clinical Trial Evaluating Satisfaction and Experiences with a Dexamethasone Mouth Film Compared to Corticosteroid Tablets as Rescue Medication for Moderate to Severe Acute Allergic ReactionsLeif Bjermer, Göran Tornling, James Kereki, et al.Journal of Market Access & Health Policy|April 29, 2016
Vaccination: short- to long-term benefits from investmentStuart Carroll, Amós José García Rojas, Anna H Glenngård, et al.Journal of Market Access & Health Policy|April 29, 2016
Reimbursement of licensed cell and gene therapies across the major European healthcare marketsJesper Jørgensen, Panos KefalasJournal of Market Access & Health Policy|April 29, 2016
The intangible benefits of vaccination - what is the true economic value of vaccination?Paolo Bonanni, Juan José Picazo, Vanessa RémyJournal of Market Access & Health Policy|April 29, 2016
Efficacy, tolerability, and safety of aripiprazole once-monthly versus other long-acting injectable antipsychotic therapies in the maintenance treatment of schizophrenia: a mixed treatment comparison of double-blind randomized clinical trialsIstvan M Majer, Fiona Gaughran, Christophe Sapin, et al.Pageof 35